Transurethral electrovaporization of the prostate for benign prostatic hyperplasia in reports of 1820 cases
Degang Ding
Abstract
Degang Ding
Abstract
Objective To study the cause,prophylaxis and treatment of the complications due to transurethral electrovaporization of the prostate.Methods Transurethral electrovaporization of the prostate was performed in 1820 patients with benign prostatic hyperplasia.Results Of these 1820 cases,856 cases were followed up for 1 to 7 years after operation.International Prostatic Symptom Score was decreased from 29.1±2.7 to 10.4±2.1,QOL from 5.2±0.7 to 1.7±0.3,UR from((150.3)±52.0) mL to(21.3±12.3) mL,Qmax increased from(6.8±1.1) to(34.2±3.5) mL/s,average flow-rate from(4.3±0.8) to(10.2±1.5) mL/s.There was significant difference before and after operation(P0.05).Various severe complications occurred in 59 cases,TURS in 3 cases,over bleeding in 15 cases,urine incontinence in 1 cases,sluggish bleeding in 16 cases,opening operation in 12 cases,urethra straitness in 8 cases,ure-infection cases in 4 cases.Conclusion Transurethral electrovaporization of the prostate is the most effective way to treat benign prostatic hyperplasia.The skilled operation can reduce various complications.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the cause,prophylaxis and treatment of the complications due to transurethral electrovaporization of the prostate.Methods Transurethral electrovaporization of the prostate was performed in 1820 patients with benign prostatic hyperplasia.Results Of these 1820 cases,856 cases were followed up for 1 to 7 years after operation.International Prostatic Symptom Score was decreased from 29.1±2.7 to 10.4±2.1,QOL from 5.2±0.7 to 1.7±0.3,UR from((150.3)±52.0) mL to(21.3±12.3) mL,Qmax increased from(6.8±1.1) to(34.2±3.5) mL/s,average flow-rate from(4.3±0.8) to(10.2±1.5) mL/s.There was significant difference before and after operation(P0.05).Various severe complications occurred in 59 cases,TURS in 3 cases,over bleeding in 15 cases,urine incontinence in 1 cases,sluggish bleeding in 16 cases,opening operation in 12 cases,urethra straitness in 8 cases,ure-infection cases in 4 cases.Conclusion Transurethral electrovaporization of the prostate is the most effective way to treat benign prostatic hyperplasia.The skilled operation can reduce various complications.
Key concepts: Medicine, Hyperplasia, Prostate, Urology, International Prostate Symptom Score, Transurethral resection of the prostate, Internal medicine, Lower urinary tract symptoms